Bayer invests $2.2 billion in US vaccine plant
Statements (2)
- Neutral
Bayer AG is investing up to $2.2 billion in a new pharmaceutical manufacturing site in New Albany, Ohio
- Neutral
Bayer is investing $2.2 billion in a US drug plant to produce vaccines against COVID-19